By Ben Hirschler LONDON (Reuters) - The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a... ...http://www.sify.com/finance/drug-approvals-bounce-back-as-rd-labs-churn-out-new-winners-news-others-rfzsHDcbadfhc.html
US federal regulators have given the green light to French pharmaceutical company Sanofi and its US partner Regeneron to market a drug to treat the... ...http://www.business-standard.com/article/pti-stories/us-approves-sanofi-regeneron-arthritis-drug-117052300738_1.html
India is expected to roll out a new drug policy and devise rules for clinical trials that may bring new projects to the country, a top Indian... ...http://www.deccanherald.com/content/612579/india-unveil-drug-policy-officials.html
* Pricing regulator queries 65 domestic and globaldrugmakers * Tells drugmakers to respond by June 15 * Action targets 300 medicines India... ...http://www.sify.com/news/update-1-indias-drug-pricing-regulator-clamps-down-on-drug-cocktails-news-crime-rfsquxibebbig.html
Tata Motors - DVR, IIFL Holdings, Sanofi India and Shree Cement are among the other stocks to see a surge in volumes on BSE today, 17 May 2017. ...http://www.business-standard.com/article/news-cm/volumes-jump-at-capital-first-counter-117051700487_1.html
Radisson Blu Hotel New Delhi Paschim...